Steven Cohen Point72 Asset Management
Steven Cohen is the founder of Point72 Asset Management and previously built SAC Capital into one of the industry’s most profitable trading firms. Point72 operates a multi-manager platform combining fundamental long/short equity with systematic and other strategies. Cohen is also a major figure in sports ownership and philanthropy, while remaining one of the most closely followed names in hedge fund trading culture.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$284M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$243M |
| 3 |
Eli Lilly
LLY
|
+$204M |
| 4 |
Meta Platforms (Facebook)
META
|
+$191M |
| 5 |
Microsoft
MSFT
|
+$134M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IMMU
Immunomedics Inc
IMMU
|
+$205M |
| 2 |
Merck
MRK
|
+$169M |
| 3 |
Canadian National Railway
CNI
|
+$131M |
| 4 |
NXP Semiconductors
NXPI
|
+$119M |
| 5 |
Fidelity National Information Services
FIS
|
+$119M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.77% |
| 2 | Technology | 20.47% |
| 3 | Consumer Discretionary | 13.53% |
| 4 | Financials | 8.97% |
| 5 | Communication Services | 7.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Blackstone
BX
$108B
| $22M | 0.11% |
+421,603
| New | +$22.6M |
|
|
QTS
252
DELISTED
QTS REALTY TRUST, INC.
QTS
| $22M | 0.11% |
348,657
+216,544
| +164% | +$14.4M |
|
253
Kohl's
KSS
$2.06B
| $21.9M | 0.11% |
+1,179,981
| New | +$25M |
|
254
McDonald's
MCD
$193B
| $21.9M | 0.11% |
+99,604
| New | +$20.4M |
|
|
FOLD
255
DELISTED
Amicus Therapeutics
FOLD
| $21.8M | 0.11% |
1,541,042
+522,513
| +51% | +$7.62M |
|
256
CALL
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.9B
| $21.7M | 0.11% |
161,000
+125,000
| +347% | +$17M |
|
|
CNST
257
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $21.7M | 0.11% |
1,069,994
+383,274
| +56% | +$9.36M |
|
258
Hyatt Hotels
H
$16.9B
| $21.5M | 0.11% |
403,469
-201,831
| -33% | -$10.8M |
|
259
Guardant Health
GH
$22.3B
| $21.4M | 0.11% |
+191,216
| New | +$17.5M |
|
260
Flex
FLEX
$39.6B
| $21.3M | 0.11% |
2,531,337
-1,666,060
| -40% | -$13.6M |
|
261
Zebra Technologies
ZBRA
$17B
| $20.8M | 0.11% |
82,548
-21,214
| -20% | -$5.71M |
|
|
WPX
262
DELISTED
WPX Energy, Inc.
WPX
| $20.7M | 0.11% |
+4,226,628
| New | +$23.4M |
|
263
Intel
INTC
$463B
| $20.7M | 0.11% |
+399,390
| New | +$20.8M |
|
|
KDMN
264
DELISTED
Kadmon Holdings, Inc.
KDMN
| $20.7M | 0.11% |
5,274,076
-53,850
| -1% | -$226K |
|
265
JPMorgan Chase
JPM
$946B
| $20.6M | 0.11% |
214,500
+154,500
| +258% | +$15.2M |
|
|
NVRO
266
DELISTED
NEVRO CORP.
NVRO
| $20.5M | 0.11% |
+147,441
| New | +$19.7M |
|
267
Copa Holdings
CPA
$5.98B
| $20.4M | 0.1% |
404,361
-36,372
| -8% | -$1.84M |
|
268
Fair Isaac
FICO
$25B
| $20.3M | 0.1% |
47,787
+14,871
| +45% | +$6.32M |
|
269
Waters Corp
WAT
$40B
| $20.2M | 0.1% |
+103,290
| New | +$21.5M |
|
270
Revolve Group
RVLV
$1.7B
| $20.2M | 0.1% |
1,228,268
+959,839
| +358% | +$17.3M |
|
271
CoStar Group
CSGP
$13.1B
| $20M | 0.1% |
236,000
-206,420
| -47% | -$16.5M |
|
|
AAN.A
272
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $20M | 0.1% |
+352,812
| New | +$20M |
|
273
Suncor Energy
SU
$78.6B
| $20M | 0.1% |
1,635,000
-31,149
| -2% | -$488K |
|
274
Walt Disney
DIS
$190B
| $19.9M | 0.1% |
+160,365
| New | +$20M |
|
275
OraSure Technologies
OSUR
$262M
| $19.6M | 0.1% |
1,609,140
+61,992
| +4% | +$847K |
|
Similar funds
Steven Cohen's Q3 2020 Portfolio in Review
As of Q3 2020, Steven Cohen held 1,184 positions worth $19.5B, up 27% from $15.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Steven Cohen deployed $3.06B of net new capital in Q3 2020, opening 406 new positions and adding to 253 existing holdings. Its largest new stake was Palantir: 29,904,230 shares worth $284M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Immunomedics Inc, an estimated $205M trimmed.
- Steven Cohen's largest Q3 2020 buy was Palantir: 29,904,230 shares worth $284M.
- Steven Cohen added most to Alphabet (Google) Class A in Q3 2020, an estimated $243M increase.
- Steven Cohen's biggest Q3 2020 reduction was Immunomedics Inc, cutting an estimated $205M.
- Steven Cohen fully exited Salesforce in Q3 2020, selling an estimated $105M.
- Steven Cohen's ten largest holdings make up 16% of its $19.5B portfolio in Q3 2020.
- Steven Cohen opened 406 new positions and closed 288 in Q3 2020.
- Steven Cohen's portfolio value rose 27% quarter-over-quarter to $19.5B.
Based on Point72 Asset Management's 13F filing for Q3 2020, filed 16 Nov 2020.